시장보고서
상품코드
1472029

세계의 약물전달 기술 시장(2024-2034년)

Drug Delivery Technologies Market Report 2024-2034

발행일: | 리서치사: Visiongain Reports Ltd. | 페이지 정보: 영문 328 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 약물전달 기술 시장 규모는 2034년까지 5.5%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

약물전달 기술의 성장은 만성질환의 확산, 생물학적 제제 시장의 급성장, R&D 투자 증가, 기술 혁신, 신제품 출시 등 여러 가지 주요 요인에 의해 촉진되고 있습니다. 또한, 제약 및 바이오 제약 기업들은 다양한 치료 목적과 혁신적인 약물전달 플랫폼에 맞는 새로운 분자체를 개발하기 위해 R&D에 전략적으로 자원을 투자하고 있습니다. 이들 기업은 우수한 품질의 혁신적 제품을 시장에 출시하기 위해 R&D에 많은 투자를 하고 있습니다. 특히, 바이오 제약사들의 R&D에 대한 자금 배분은 시간이 지남에 따라 크게 증가하고 있습니다. 그러나 바늘에 찔릴 위험 증가와 가격 상승 압력 등 당장 시장 성장에 대한 잠재적 제약 요인을 인식하는 것이 필수적입니다.

세계 약물전달 기술(Drug Delivery Technology) 시장을 조사했으며, 시장 개요, 시장 성장에 영향을 미치는 요인 및 시장 기회 분석, 시장 규모 추이 및 예측, 각 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 보고서 개요

제2장 주요 요약

제3장 시장 개요

  • 주요 조사 결과
  • 시장 역학
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
    • 시장 기회
  • COVID-19의 영향 분석
  • Porter의 Five Forces 분석
  • PEST 분석

제4장 약물전달 기술 시장 분석 : 투여 경로별

  • 주요 조사 결과
  • 시장의 매력 지수
  • 시장 규모 추이와 예측
  • 이식 약물전달
  • 주사 약물전달
  • 비강내 약물전달
  • 안과 약물전달
  • 경구 약물전달
  • 경폐 약물전달
  • 국소 약물전달
  • 경점막 약물전달
    • 시장 규모 추이와 예측 : 지역별
    • 시장 점유율 : 지역별

제5장 약물전달 기술 시장 분석 : 용도별의 약물전달 기술 시장 분석

  • 주요 조사 결과
  • 시장의 매력 지수
  • 시장 규모 추이와 예측
  • 심장혈관
  • 당뇨병
  • 감염증
  • 기타
    • 시장 규모 추이와 예측 : 지역별
    • 시장 점유율 : 지역별

제6장 약물전달 기술 시장 분석 : 최종사용자별

  • 주요 조사 결과
  • 시장의 매력 지수
  • 시장 규모 추이와 예측
  • 외래수술센터(ASC)
  • 병원
  • 홈케어
  • 기타
    • 시장 규모 추이와 예측 : 지역별
    • 시장 점유율 : 지역별

제7장 약물전달 기술 시장 분석 : 지역별

  • 주요 조사 결과
  • 시장 규모 추이와 예측

제8장 북미의 약물전달 기술 시장 분석

제9장 유럽의 약물전달 기술 시장 분석

제10장 아시아태평양의 약물전달 기술 시장 분석

제11장 라틴아메리카의 약물전달 기술 시장 분석

제12장 중동 및 아프리카의 약물전달 기술 시장 분석

제13장 기업 개요

  • Johnson &Johnson Services, Inc.
  • Novartis AG
  • F. Hoffmann-La Roche Ltd.
  • Pfizer Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • GSK plc
  • Merck &Co., Inc.
  • Sanofi
  • Amgen Inc.
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • Boehringer Ingelheim
  • AstraZeneca plc
  • Eli Lilly and Company
  • Teva Pharmaceuticals Industries Ltd.
  • Bristol-Myers Squibb
  • Gerresheimer AG
  • Boston Scientific Corporation

제14장 결론 및 제안

  • Visiongain의 결론
  • 참여 기업을 위한 추천 사항
LSH 24.05.08

The global Drug Delivery Technologies market is projected to grow at a CAGR of 5.5% by 2034

The Drug Delivery Technologies Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

The expansion observed in the drug delivery technologies sector can be largely attributed to several key drivers. These include the escalating prevalence of chronic ailments, the burgeoning biologics market, heightened investments in research and development, technological breakthroughs, and the introduction of novel products. Additionally, pharmaceutical and biopharmaceutical enterprises are strategically directing resources towards research and development endeavours aimed at cultivating new molecular entities tailored for diverse therapeutic applications and innovative drug delivery platforms. These companies are committed to substantial investments in research and development endeavours to ensure the delivery of superior-quality and ground-breaking products to the marketplace. Notably, the allocation of funds towards research and development by biopharmaceutical entities has witnessed a significant uptick over time. However, it's imperative to acknowledge potential constraints to market growth in the foreseeable future, such as the heightened risk of needlestick injuries and escalating pricing pressures.

What Questions Should You Ask before Buying a Market Research Report?

How is the drug delivery technologies market evolving?

What is driving and restraining the drug delivery technologies market?

How will each drug delivery technologies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each drug delivery technologies submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading drug delivery technologies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the drug delivery technologies projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of

drug delivery technologies projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the drug delivery technologies market?

Where is the drug delivery technologies market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the drug delivery technologies market today, and over the next 10 years:

Our 328-page report provides 121 tables, 184 charts/graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the drug delivery technologies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

Route of Administration

Implantable Drug Delivery

Injectable Drug Delivery

Nasal Drug Delivery

Ocular Drug Delivery

Oral Drug Delivery

Pulmonary Drug Delivery

Topical Drug Delivery

Transmucosal Drug Delivery

Application

Cancer

Cardiovascular

Diabetes

Infectious Diseases

Others

End-users

Ambulatory Surgical Centres

Hospitals

Home Care Settings

Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 21 leading national markets:

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Rest of Europe

Asia Pacific

Japan

China

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

MEA

GCC

South Africa

Rest of MEA

The report also includes profiles and for some of the leading companies in the Drug Delivery Technologies Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

AbbVie Inc.

Amgen Inc.

AstraZeneca plc

Bayer AG

BD

Boehringer Ingelheim

Boston Scientific Corporation

Bristol-Myers Squibb

Eli Lilly and Company

F. Hoffmann-La Roche Ltd.

Gerresheimer AG

Gilead Sciences, Inc.

GSK plc

Johnson & Johnson Services, Inc.

Novartis AG

Merck & Co., Inc.

Pfizer Inc.

Sanofi

Teva Pharmaceuticals Industries Ltd.

Overall world revenue for Drug Delivery Technologies Market, 2024 to 2034 in terms of value the market will surpass US$1,700 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Drug Delivery Technologies Market, 2024 to 2034 report help you?

In summary, our 320+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Drug Delivery Technologies Market 2024 to 2034, with forecasts for route of administration, application, and end-users each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2034 for five regional and 21 key national markets - See forecasts for the Drug Delivery Technologies Market, 2024 to 2034 in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 19 of the major companies involved in the Drug Delivery Technologies Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Drug Delivery Technologies Market 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Drug Delivery Technologies Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Rising Prevalence of Chronic Diseases
      • 3.2.1.2 Technological Advancements Driving Industry Growth
      • 3.2.1.3 Rising Focus on Patient-centric Care
      • 3.2.1.4 Integration of AI and Big Data
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Lack of Awareness and Infrastructure
      • 3.2.2.2 Risk of Needlestick Injuries
      • 3.2.2.3 Reimbursement Issues in Advanced Drug Delivery Technologies
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Self-administration and Home Care
      • 3.2.3.2 Digital Integration and Connectivity
      • 3.2.3.3 Expanding Applications in Biologics and Gene Therapies
      • 3.2.3.4 Sustainable and Eco-friendly Innovations in Drug Delivery Technologies
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Supplier Power
    • 3.4.2 Buyer Power
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat of Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Drug Delivery Technologies Market Analysis by Route of Administration

  • 4.1 Key Findings
  • 4.2 Route of Administration Segment: Market Attractiveness Index
  • 4.3 Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
  • 4.4 Implantable Drug Delivery
    • 4.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5 Injectable Drug Delivery
    • 4.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.5.2 Market Share by Region, 2024 & 2034 (%)
  • 4.6 Nasal Drug Delivery
    • 4.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.6.2 Market Share by Region, 2024 & 2034 (%)
  • 4.7 Ocular Drug Delivery
    • 4.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.7.2 Market Share by Region, 2024 & 2034 (%)
  • 4.8 Oral Drug Delivery
    • 4.8.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.8.2 Market Share by Region, 2024 & 2034 (%)
  • 4.9 Pulmonary Drug Delivery
    • 4.9.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.9.2 Market Share by Region, 2024 & 2034 (%)
  • 4.10 Topical Drug Delivery
    • 4.10.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.10.2 Market Share by Region, 2024 & 2034 (%)
  • 4.11 Transmucosal Drug Delivery
    • 4.11.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.11.2 Market Share by Region, 2024 & 2034 (%)

5 Drug Delivery Technologies Market Analysis by Application

  • 5.1 Key Findings
  • 5.2 Application Segment: Market Attractiveness Index
  • 5.3 Drug Delivery Technologies Market Size Estimation and Forecast by Application
  • 5.4 Cancer
    • 5.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.4.2 Market Share by Region, 2024 & 2034 (%)
  • 5.5 Cardiovascular
    • 5.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.5.2 Market Share by Region, 2024 & 2034 (%)
  • 5.6 Diabetes
    • 5.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.6.2 Market Share by Region, 2024 & 2034 (%)
  • 5.7 Infectious Diseases
    • 5.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.7.2 Market Share by Region, 2024 & 2034 (%)
  • 5.8 Others
    • 5.8.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.8.2 Market Share by Region, 2024 & 2034 (%)

6 Drug Delivery Technologies Market Analysis by End-users

  • 6.1 Key Findings
  • 6.2 End-users Segment: Market Attractiveness Index
  • 6.3 Drug Delivery Technologies Market Size Estimation and Forecast by End-users
  • 6.4 Ambulatory Surgical Centres
    • 6.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 6.4.2 Market Share by Region, 2024 & 2034 (%)
  • 6.5 Hospitals
    • 6.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 6.5.2 Market Share by Region, 2024 & 2034 (%)
  • 6.6 Home Care Settings
    • 6.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 6.6.2 Market Share by Region, 2024 & 2034 (%)
  • 6.7 Others
    • 6.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 6.7.2 Market Share by Region, 2024 & 2034 (%)

7 Drug Delivery Technologies Market Analysis by Region

  • 7.1 Key Findings
  • 7.2 Regional Market Size Estimation and Forecast

8 North America Drug Delivery Technologies Market Analysis

  • 8.1 Key Findings
  • 8.2 North America Drug Delivery Technologies Market Attractiveness Index
  • 8.3 North America Drug Delivery Technologies Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 8.4 North America Drug Delivery Technologies Market Size Estimation and Forecast by Country
  • 8.5 North America Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
  • 8.6 North America Drug Delivery Technologies Market Size Estimation and Forecast by Application
  • 8.7 North America Drug Delivery Technologies Market Size Estimation and Forecast by End-users
  • 8.8 U.S. Drug Delivery Technologies Market Analysis
  • 8.9 Canada Drug Delivery Technologies Market Analysis

9 Europe Drug Delivery Technologies Market Analysis

  • 9.1 Key Findings
  • 9.2 Europe Drug Delivery Technologies Market Attractiveness Index
  • 9.3 Europe Drug Delivery Technologies Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 9.4 Europe Drug Delivery Technologies Market Size Estimation and Forecast by Country
  • 9.5 Europe Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
  • 9.6 Europe Drug Delivery Technologies Market Size Estimation and Forecast by Application
  • 9.7 Europe Drug Delivery Technologies Market Size Estimation and Forecast by End-users
  • 9.8 Germany Drug Delivery Technologies Market Analysis
  • 9.9 UK Drug Delivery Technologies Market Analysis
  • 9.10 France Drug Delivery Technologies Market Analysis
  • 9.11 Italy Drug Delivery Technologies Market Analysis
  • 9.12 Spain Drug Delivery Technologies Market Analysis
  • 9.13 Russia Drug Delivery Technologies Market Analysis
  • 9.14 Rest of Europe Drug Delivery Technologies Market Analysis

10 Asia Pacific Drug Delivery Technologies Market Analysis

  • 10.1 Key Findings
  • 10.2 Asia Pacific Drug Delivery Technologies Market Attractiveness Index
  • 10.3 Asia Pacific Drug Delivery Technologies Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 10.4 Asia Pacific Drug Delivery Technologies Market Size Estimation and Forecast by Country
  • 10.5 Asia Pacific Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
  • 10.6 Asia Pacific Drug Delivery Technologies Market Size Estimation and Forecast by Application
  • 10.7 Asia Pacific Drug Delivery Technologies Market Size Estimation and Forecast by End-users
  • 10.8 Japan Drug Delivery Technologies Market Analysis
  • 10.9 China Drug Delivery Technologies Market Analysis
  • 10.10 India Drug Delivery Technologies Market Analysis
  • 10.11 Australia Drug Delivery Technologies Market Analysis
  • 10.12 South Korea Drug Delivery Technologies Market Analysis
  • 10.13 South-East Asia Drug Delivery Technologies Market Analysis
  • 10.14 Rest of Asia Pacific Drug Delivery Technologies Market Analysis

11 Latin America Drug Delivery Technologies Market Analysis

  • 11.1 Key Findings
  • 11.2 Latin America Drug Delivery Technologies Market Attractiveness Index
  • 11.3 Latin America Drug Delivery Technologies Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 11.4 Latin America Drug Delivery Technologies Market Size Estimation and Forecast by Country
  • 11.5 Latin America Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
  • 11.6 Latin America Drug Delivery Technologies Market Size Estimation and Forecast by Application
  • 11.7 Latin America Drug Delivery Technologies Market Size Estimation and Forecast by End-users
  • 11.8 Brazil Drug Delivery Technologies Market Analysis
  • 11.9 Mexico Drug Delivery Technologies Market Analysis
  • 11.10 Rest of Latin America Drug Delivery Technologies Market Analysis

12 MEA Drug Delivery Technologies Market Analysis

  • 12.1 Key Findings
  • 12.2 MEA Drug Delivery Technologies Market Attractiveness Index
  • 12.3 MEA Drug Delivery Technologies Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 12.4 MEA Drug Delivery Technologies Market Size Estimation and Forecast by Country
  • 12.5 MEA Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
  • 12.6 MEA Drug Delivery Technologies Market Size Estimation and Forecast by Application
  • 12.7 MEA Drug Delivery Technologies Market Size Estimation and Forecast by End-users
  • 12.8 GCC Drug Delivery Technologies Market Analysis
  • 12.9 South Africa Drug Delivery Technologies Market Analysis
  • 12.10 Rest of MEA Drug Delivery Technologies Market Analysis

13 Company Profiles

  • 13.1 Johnson & Johnson Services, Inc.
    • 13.1.1 Company Snapshot
    • 13.1.2 Company Overview
    • 13.1.3 Financial Analysis
      • 13.1.3.1 Net Revenue, 2015-2023
      • 13.1.3.2 Regional Market Shares, 2023
      • 13.1.3.3 R&D, 2015-2023
    • 13.1.4 Product Benchmarking
  • 13.2 Novartis AG
    • 13.2.1 Company Snapshot
    • 13.2.2 Company Overview
    • 13.2.3 Financial Analysis
      • 13.2.3.1 Net Revenue, 2015-2023
      • 13.2.3.2 Regional Market Shares, 2023
      • 13.2.3.3 R&D, 2015-2023
    • 13.2.4 Product Benchmarking
    • 13.2.5 Strategic Outlook
  • 13.3 F. Hoffmann-La Roche Ltd.
    • 13.3.1 Company Snapshot
    • 13.3.2 Company Overview
    • 13.3.3 Financial Analysis
      • 13.3.3.1 Net Revenue, 2015-2023
      • 13.3.3.2 Regional Market Shares, 2023
      • 13.3.3.3 R&D, 2015-2023
    • 13.3.4 Product Benchmarking
    • 13.3.5 Strategic Outlook
  • 13.4 Pfizer Inc.
    • 13.4.1 Company Snapshot
    • 13.4.2 Company Overview
    • 13.4.3 Financial Analysis
      • 13.4.3.1 Net Revenue, 2015-2023
      • 13.4.3.2 Regional Market Shares, 2023
      • 13.4.3.3 R&D, 2015-2023
    • 13.4.4 Product Benchmarking
    • 13.4.5 Strategic Outlook
  • 13.5 Bayer AG
    • 13.5.1 Company Snapshot
    • 13.5.2 Company Overview
    • 13.5.3 Financial Analysis
      • 13.5.3.1 Net Revenue, 2015-2022
      • 13.5.3.2 Regional Market Shares, 2022
      • 13.5.3.3 R&D, 2015-2022
    • 13.5.4 Product Benchmarking
    • 13.5.5 Strategic Outlook
  • 13.6 Becton, Dickinson and Company
    • 13.6.1 Company Snapshot
    • 13.6.2 Company Overview
    • 13.6.3 Financial Analysis
      • 13.6.3.1 Net Revenue, 2015-2023
      • 13.6.3.2 Regional Market Shares, 2023
      • 13.6.3.3 R&D, 2015-2023
    • 13.6.4 Product Benchmarking
    • 13.6.5 Strategic Outlook
  • 13.7 GSK plc
    • 13.7.1 Company Snapshot
    • 13.7.2 Company Overview
    • 13.7.3 Financial Analysis
      • 13.7.3.1 Net Revenue, 2015-2023
      • 13.7.3.2 Regional Market Shares, 2023
      • 13.7.3.3 R&D, 2015-2023
    • 13.7.4 Product Benchmarking
  • 13.8 Merck & Co., Inc.
    • 13.8.1 Company Snapshot
    • 13.8.2 Company Overview
    • 13.8.3 Financial Analysis
      • 13.8.3.1 Net Revenue, 2015-2023
      • 13.8.3.2 Regional Market Shares, 2023
      • 13.8.3.3 R&D, 2015-2023
    • 13.8.4 Product Benchmarking
    • 13.8.5 Strategic Outlook
  • 13.9 Sanofi
    • 13.9.1 Company Snapshot
    • 13.9.2 Company Overview
    • 13.9.3 Financial Analysis
      • 13.9.3.1 Net Revenue, 2015-2023
      • 13.9.3.2 Regional Market Shares, 2023
      • 13.9.3.3 R&D, 2015-2023
    • 13.9.4 Product Benchmarking
    • 13.9.5 Strategic Outlook
  • 13.10 Amgen Inc.
    • 13.10.1 Company Snapshot
    • 13.10.2 Company Overview
    • 13.10.3 Financial Analysis
      • 13.10.3.1 Net Revenue, 2015-2023
      • 13.10.3.2 R&D, 2015-2023
      • 13.10.3.3 Regional Market Shares, 2023
    • 13.10.4 Product Benchmarking
    • 13.10.5 Strategic Outlook
  • 13.11 AbbVie Inc.
    • 13.11.1 Company Snapshot
    • 13.11.2 Company Overview
    • 13.11.3 Financial Analysis
      • 13.11.3.1 Net Revenue, 2015-2023
      • 13.11.3.2 Regional Market Shares, 2023
      • 13.11.3.3 R&D, 2015-2023
    • 13.11.4 Product Benchmarking
    • 13.11.5 Strategic Outlook
  • 13.12 Gilead Sciences, Inc.
    • 13.12.1 Company Snapshot
    • 13.12.2 Company Overview
    • 13.12.3 Financial Analysis
      • 13.12.3.1 Net Revenue, 2015-2023
      • 13.12.3.2 R&D, 2015-2023
    • 13.12.4 Product Benchmarking
    • 13.12.5 Strategic Outlook
  • 13.13 Boehringer Ingelheim
    • 13.13.1 Company Snapshot
    • 13.13.2 Company Overview
    • 13.13.3 Financial Analysis
      • 13.13.3.1 Net Revenue, 2015-2022
      • 13.13.3.2 Regional Market Shares, 2022
    • 13.13.4 Product Benchmarking
  • 13.14 AstraZeneca plc
    • 13.14.1 Company Snapshot
    • 13.14.2 Company Overview
    • 13.14.3 Financial Analysis
      • 13.14.3.1 Net Revenue, 2015-2023
      • 13.14.3.2 Regional Market Shares, 2023
      • 13.14.3.3 R&D, 2015-2022
    • 13.14.4 Product Benchmarking
    • 13.14.5 Strategic Outlook
  • 13.15 Eli Lilly and Company
    • 13.15.1 Company Snapshot
    • 13.15.2 Company Overview
    • 13.15.3 Financial Analysis
      • 13.15.3.1 Net Revenue, 2015-2022
      • 13.15.3.2 Regional Market Shares, 2023
      • 13.15.3.3 R&D, 2015-2022
    • 13.15.4 Product Benchmarking
    • 13.15.5 Strategic Outlook
  • 13.16 Teva Pharmaceuticals Industries Ltd.
    • 13.16.1 Company Snapshot
    • 13.16.2 Company Overview
    • 13.16.3 Financial Analysis
      • 13.16.3.1 Net Revenue, 2015-2022
      • 13.16.3.2 Regional Market Shares, 2023
      • 13.16.3.3 R&D, 2015-2022
    • 13.16.4 Product Benchmarking
    • 13.16.5 Strategic Outlook
  • 13.17 Bristol-Myers Squibb
    • 13.17.1 Company Snapshot
    • 13.17.2 Company Overview
    • 13.17.3 Financial Analysis
      • 13.17.3.1 Net Revenue, 2015-2022
      • 13.17.3.2 Regional Market Shares, 2023
      • 13.17.3.3 R&D, 2015-2022
    • 13.17.4 Product Benchmarking
  • 13.18 Gerresheimer AG
    • 13.18.1 Company Snapshot
    • 13.18.2 Company Overview
    • 13.18.3 Financial Analysis
      • 13.18.3.1 Net Revenue, 2015-2023
      • 13.18.3.2 Regional Market Shares, 2023
    • 13.18.4 Product Benchmarking
    • 13.18.5 Strategic Outlook
  • 13.19 Boston Scientific Corporation
    • 13.19.1 Company Snapshot
    • 13.19.2 Company Overview
    • 13.19.3 Financial Analysis
      • 13.19.3.1 Net Revenue, 2015-2022
      • 13.19.3.2 Regional Market Shares, 2023
      • 13.19.3.3 R&D, 2015-2022
    • 13.19.4 Product Benchmarking
    • 13.19.5 Strategic Outlook

14 Conclusion and Recommendations

  • 14.1 Concluding Remarks from Visiongain
  • 14.2 Recommendations for Market Players
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제